ADR Biomedical Holdings (TSE:3750) E10: 円-26.23 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:3750 ADR Biomedical Holdings Inc TSE:3750
24 GF Score
Price 円763.00
GF Value 円39.23
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is ADR Biomedical Holdings E10?

ADR Biomedical Holdings TSE:3750 -0.13% 24 E10 is 円-26.23 as of Mar. 2026. GuruFocus rates TSE:3750 with a GF Score™ of 24/100 and a GF Value™ of 円39.23 (Significantly Overvalued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

ADR Biomedical Holdings's adjusted earnings per share data for the three months ended in Mar. 2026 was 円-8.960. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is 円-26.23 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was -82.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of ADR Biomedical Holdings was -82.60% per year. The lowest was -82.60% per year. And the median was -82.60% per year.

As of today (2026-08-24), ADR Biomedical Holdings's current stock price is 円763.00. ADR Biomedical Holdings's E10 for the quarter that ended in Mar. 2026 was 円-26.23. ADR Biomedical Holdings's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of ADR Biomedical Holdings was 955.70. The lowest was 21.40. And the median was 111.28.


ADR Biomedical Holdings  (TSE:3750) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of ADR Biomedical Holdings was 955.70. The lowest was 21.40. And the median was 111.28.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


ADR Biomedical Holdings E10 Related Terms


ADR Biomedical Holdings E10 Historical Data

* Premium members only.

The historical data trend for ADR Biomedical Holdings's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ADR Biomedical Holdings E10 Chart

ADR Biomedical Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.94 -4.31 -8.78 0.00 -26.23

ADR Biomedical Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.67 -23.14 -25.28 -26.23 0.00

TSE:3750 vs VRTX, REGN, RVMD: E10 Comparison

For the Biotechnology subindustry, ADR Biomedical Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ADR Biomedical Holdings Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ADR Biomedical Holdings's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where ADR Biomedical Holdings's Shiller PE Ratio falls into.


TSE:3750
24GF Score
ADR Biomedical Holdings Inc TSE:3750
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ADR Biomedical Holdings E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, ADR Biomedical Holdings's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-8.96/112.7000*112.7000
=-8.960

Current CPI (Mar. 2026) = 112.7000.

ADR Biomedical Holdings Quarterly Data

per share eps CPI Adj_EPS
201603 -38.275 97.900 -44.061
201606 -27.686 98.100 -31.806
201609 -2.294 98.000 -2.638
201612 -3.482 98.400 -3.988
201703 -59.142 98.100 -67.944
201706 -9.550 98.500 -10.927
201709 -2.490 98.800 -2.840
201712 24.130 99.400 27.359
201803 54.160 99.200 61.531
201806 44.710 99.200 50.795
201809 -18.280 99.900 -20.622
201812 6.690 99.700 7.562
201903 55.176 99.700 62.370
201906 4.260 99.800 4.811
201909 -0.610 100.100 -0.687
201912 -8.186 100.500 -9.180
202003 52.110 100.300 58.552
202006 4.620 99.900 5.212
202009 -20.190 99.900 -22.777
202012 -5.131 99.300 -5.823
202103 -81.450 99.900 -91.886
202106 -10.690 99.500 -12.108
202109 6.710 100.100 7.555
202112 10.767 100.100 12.122
202203 -15.760 101.100 -17.568
202206 -32.210 101.800 -35.659
202209 -30.657 103.100 -33.512
202212 -18.090 104.100 -19.584
202303 -37.760 104.400 -40.762
202306 -18.070 105.200 -19.358
202309 -31.589 106.200 -33.522
202312 -12.250 106.800 -12.927
202403 77.370 107.200 81.340
202406 -27.160 108.200 -28.290
202409 -21.260 108.900 -22.002
202503 0.000 111.100 0.000
202506 7.820 111.700 7.890
202509 -22.510 112.000 -22.651
202512 -20.810 113.000 -20.755
202603 -8.960 112.700 -8.960

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of 円-26.23 mean?
ADR Biomedical Holdings (TSE:3750) has a E10 of 円-26.23 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on ADR Biomedical Holdings and its competitors.
Is ADR Biomedical Holdings' E10 too high?
ADR Biomedical Holdings' current E10 is 円-26.23. Overall, ADR Biomedical Holdings has a GF Score™ of 24/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ADR Biomedical Holdings' E10 compare to VRTX and REGN?
ADR Biomedical Holdings' E10 of 円-26.23 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on ADR Biomedical Holdings and its competitors. ADR Biomedical Holdings's current E10 is 円-26.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ADR Biomedical Holdings stock overvalued right now?
Based on GuruFocus' analysis, ADR Biomedical Holdings (TSE:3750) is currently considered Significantly Overvalued. The stock's GF Value™ is 円39.23, compared to a current price of 円763.00 — trading 1844.9% above its estimated fair value. The current E10 is 円-26.23. ADR Biomedical Holdings' overall GF Score™ is 24/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For ADR Biomedical Holdings (TSE:3750), the current E10 is 円-26.23 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ADR Biomedical Holdings (TSE:3750) Overvalued in 2026?

Based on GuruFocus' analysis, ADR Biomedical Holdings stock appears to be overvalued. The current stock price of 円763.00 is trading 1844.9% above its estimated GF Value™ of 円39.23. GuruFocus considers ADR Biomedical Holdings to be Significantly Overvalued.

Key valuation signals for TSE:3750:

  • E10: 円-26.23
  • GF Value™: 円39.23 vs. price of 円763.00 (1844.9% above fair value)
  • GF Score™: 24/100 with 8 warning signs

No single metric tells the full story. See the TSE:3750 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ADR Biomedical Holdings Business Description

Address 1-1-1 Otemachi, Otemachi Park Building, Chiyoda-ku, Tokyo, JPN, 100-0004
ADR120S Inc developing a new clinical approach to cell therapy to provide medical care to patients by providing medical care that responds to unmet medical needs based on its regenerative medicine. Its product pipeline includes Habeo; ECCO-50 and others.
24GF Score

Get the complete analysis for TSE:3750

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円763.00
Price
円39.23
GF Value